TALEN

TALEN1-abcc6a

ID

ZDB-TALEN-210823-1

Name

TALEN1-abcc6a

Previous Names

None

Target

abcc6a (1)

Target Sequence 1

5' - GGAATCAGACGTGGTACA - 3'

Target Sequence 2

5' - GTGTTCTGGAAGCAGTT - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

None

Genome Resources

None

Target Location

Constructs

No data available

Genomic Features

Genomic Feature	Affected Genomic Regions
zf3475	abcc6a
zf3476	abcc6a

Expression

Gene expression in Wild Types + TALEN1-abcc6a

No data available

Phenotype

Phenotype resulting from TALEN1-abcc6a

No data available

Phenotype of all Fish created by or utilizing TALEN1-abcc6a

Phenotype	Fish	Conditions	Figures
compact layer of ventricle Fibronectin amount, ameliorated	abcc6a^{zf3475/zf3475} (AB)	chemical treatment by environment: phylloquinone	Figure 4 from Sun et al., 2020
heart tncb expression increased amount, abnormal	abcc6a^{zf3475/zf3475} (AB)	standard conditions	Figure 3 from Sun et al., 2020
trunk curved, abnormal	abcc6a^{zf3475/zf3475} (AB)	standard conditions	Figure 1 from Sun et al., 2020
centrum mineral increased mass density, abnormal	abcc6a^{zf3475/zf3475} (AB)	standard conditions	Figure 1 from Sun et al., 2020
vertebra ossification increased process quality, abnormal	abcc6a^{zf3475/zf3475} (AB)	standard conditions	Figure 1 from Sun et al., 2020
trabecular layer Fibronectin increased amount, abnormal	abcc6a^{zf3475/zf3475} (AB)	control	Figure 3 , Figure 4 from Sun et al., 2020
trabecular layer Collagen amount, ameliorated	abcc6a^{zf3475/zf3475} (AB)	chemical treatment by environment: phylloquinone	Figure 4 from Sun et al., 2020
heart vitamin K amount, ameliorated	abcc6a^{zf3475/zf3475} (AB)	chemical treatment by environment: phylloquinone	Figure 4 from Sun et al., 2020
compact layer of ventricle Collagen amount, ameliorated	abcc6a^{zf3475/zf3475} (AB)	chemical treatment by environment: phylloquinone	Figure 4 from Sun et al., 2020
centrum increased volume, abnormal	abcc6a^{zf3475/zf3475} (AB)	standard conditions	Figure 1 from Sun et al., 2020
eye vitamin K decreased amount, abnormal	abcc6a^{zf3475/zf3475} (AB)	control	Figure 4 from Sun et al., 2020
skeletal muscle Gla protein amount, ameliorated	abcc6a^{zf3475/zf3475} (AB)	chemical treatment by environment: phylloquinone	Figure 4 from Sun et al., 2020
Bruch's membrane thickness, ameliorated	abcc6a^{zf3475/zf3475} (AB)	chemical treatment by environment: phylloquinone	Figure 4 from Sun et al., 2020
cardiac muscle cell decreased amount, abnormal	abcc6a^{zf3475/zf3475} (AB)	standard conditions	Figure 3 from Sun et al., 2020
heart Gla protein amount, ameliorated	abcc6a^{zf3475/zf3475} (AB)	chemical treatment by environment: phylloquinone	Figure 4 from Sun et al., 2020
axis curved, abnormal	abcc6a^{zf3475/zf3475} (AB)	standard conditions	Figure 1 from Sun et al., 2020
eye vitamin K amount, ameliorated	abcc6a^{zf3475/zf3475} (AB)	chemical treatment by environment: phylloquinone	Figure 4 from Sun et al., 2020
heart decreased size, abnormal	abcc6a^{zf3475/zf3475} (AB)	standard conditions	Figure 3 from Sun et al., 2020
Bruch's membrane increased thickness, abnormal	abcc6a^{zf3475/zf3475} (AB)	control	Figure 2 , Figure 4 from Sun et al., 2020
skeletal muscle vitamin K decreased amount, abnormal	abcc6a^{zf3475/zf3475} (AB)	control	Figure 4 from Sun et al., 2020
sclera ossification increased process quality, abnormal	abcc6a^{zf3475/zf3475} (AB)	control	Figure 2 , Figure 4 from Sun et al., 2020
whole organism abcc6a expression decreased distribution, abnormal	abcc6a^{zf3475/zf3475} (AB)	standard conditions	Figure 1 from Sun et al., 2020
eye Gla protein decreased amount, abnormal	abcc6a^{zf3475/zf3475} (AB)	control	Figure 4 from Sun et al., 2020
heart Gla protein decreased amount, abnormal	abcc6a^{zf3475/zf3475} (AB)	control	Figure 4 from Sun et al., 2020
heart col4a5 expression increased amount, abnormal	abcc6a^{zf3475/zf3475} (AB)	standard conditions	Figure 3 from Sun et al., 2020
skeletal muscle Gla protein decreased amount, abnormal	abcc6a^{zf3475/zf3475} (AB)	control	Figure 4 from Sun et al., 2020
trunk kinked, abnormal	abcc6a^{zf3475/zf3475} (AB)	standard conditions	Figure 1 from Sun et al., 2020
liver vitamin K increased amount, abnormal	abcc6a^{zf3475/zf3475} (AB)	chemical treatment by environment: phylloquinone	Figure 4 from Sun et al., 2020
heart fibrotic, abnormal	abcc6a^{zf3475/zf3475} (AB)	control	Figure 3 , Figure 4 from Sun et al., 2020
compact layer of ventricle Elastin increased amount, abnormal	abcc6a^{zf3475/zf3475} (AB)	standard conditions	Figure 3 from Sun et al., 2020
liver Gla protein increased amount, abnormal	abcc6a^{zf3475/zf3475} (AB)	chemical treatment by environment: phylloquinone	Figure 4 from Sun et al., 2020
trabecular layer Elastin increased amount, abnormal	abcc6a^{zf3475/zf3475} (AB)	standard conditions	Figure 3 from Sun et al., 2020
heart vitamin K decreased amount, abnormal	abcc6a^{zf3475/zf3475} (AB)	control	Figure 4 from Sun et al., 2020
whole organism abcc6a expression decreased amount, abnormal	abcc6a^{zf3475/zf3475} (AB)	standard conditions	Figure 1 from Sun et al., 2020
heart col2a1b expression increased amount, abnormal	abcc6a^{zf3475/zf3475} (AB)	standard conditions	Figure 3 from Sun et al., 2020
trabecular layer Collagen increased amount, abnormal	abcc6a^{zf3475/zf3475} (AB)	control	Figure 3 , Figure 4 from Sun et al., 2020
sclera ossification process quality, ameliorated	abcc6a^{zf3475/zf3475} (AB)	chemical treatment by environment: phylloquinone	Figure 4 from Sun et al., 2020
compact layer of ventricle Fibronectin increased amount, abnormal	abcc6a^{zf3475/zf3475} (AB)	control	Figure 3 , Figure 4 from Sun et al., 2020
whole organism decreased length, abnormal	abcc6a^{zf3475/zf3475} (AB)	standard conditions	Figure 1 from Sun et al., 2020
compact layer of ventricle decreased thickness, abnormal	abcc6a^{zf3475/zf3475} (AB)	standard conditions	Figure 3 from Sun et al., 2020
skeletal muscle vitamin K amount, ameliorated	abcc6a^{zf3475/zf3475} (AB)	chemical treatment by environment: phylloquinone	Figure 4 from Sun et al., 2020
blood plasma Gla protein amount, ameliorated	abcc6a^{zf3475/zf3475} (AB)	chemical treatment by environment: phylloquinone	Figure 4 from Sun et al., 2020
blood plasma vitamin K decreased amount, abnormal	abcc6a^{zf3475/zf3475} (AB)	control	Figure 4 from Sun et al., 2020
compact layer of ventricle Collagen increased amount, abnormal	abcc6a^{zf3475/zf3475} (AB)	control	Figure 3 , Figure 4 from Sun et al., 2020
axis kinked, abnormal	abcc6a^{zf3475/zf3475} (AB)	standard conditions	Figure 1 from Sun et al., 2020
heart col17a1b expression increased amount, abnormal	abcc6a^{zf3475/zf3475} (AB)	standard conditions	Figure 3 from Sun et al., 2020
trabecular layer Fibronectin amount, ameliorated	abcc6a^{zf3475/zf3475} (AB)	chemical treatment by environment: phylloquinone	Figure 4 from Sun et al., 2020
heart col2a1a expression increased amount, abnormal	abcc6a^{zf3475/zf3475} (AB)	standard conditions	Figure 3 from Sun et al., 2020
heart tnr expression increased amount, abnormal	abcc6a^{zf3475/zf3475} (AB)	standard conditions	Figure 3 from Sun et al., 2020
blood plasma Gla protein decreased amount, abnormal	abcc6a^{zf3475/zf3475} (AB)	control	Figure 4 from Sun et al., 2020
heart composition, ameliorated	abcc6a^{zf3475/zf3475} (AB)	chemical treatment by environment: phylloquinone	Figure 4 from Sun et al., 2020
heart fn1b expression increased amount, abnormal	abcc6a^{zf3475/zf3475} (AB)	standard conditions	Figure 3 from Sun et al., 2020
blood plasma vitamin K amount, ameliorated	abcc6a^{zf3475/zf3475} (AB)	chemical treatment by environment: phylloquinone	Figure 4 from Sun et al., 2020
eye Gla protein amount, ameliorated	abcc6a^{zf3475/zf3475} (AB)	chemical treatment by environment: phylloquinone	Figure 4 from Sun et al., 2020
centrum mineral increased mass density, abnormal	abcc6a^{zf3476/zf3476} (AB)	standard conditions	Figure 1 from Sun et al., 2020
centrum increased volume, abnormal	abcc6a^{zf3476/zf3476} (AB)	standard conditions	Figure 1 from Sun et al., 2020
sclera ossification increased process quality, abnormal	abcc6a^{zf3476/zf3476} (AB)	standard conditions	Figure 2 from Sun et al., 2020
whole organism abcc6a expression decreased distribution, abnormal	abcc6a^{zf3476/zf3476} (AB)	standard conditions	Figure 1 from Sun et al., 2020
whole organism abcc6a expression decreased amount, abnormal	abcc6a^{zf3476/zf3476} (AB)	standard conditions	Figure 1 from Sun et al., 2020

Citations